Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Small Cell Neuroendocrine Carcinoma”

378 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 378 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339176
What this trial is testing

Intratumoral N17350 in Advanced Solid Tumors

Who this might be right for
Neoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more
Onchilles Pharma Inc 275
Early research (Phase 1)Not Yet RecruitingNCT06067776
What this trial is testing

Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
Jonathan Riess 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT02888743
What this trial is testing

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage IV Colorectal Cancer AJCC v7+3 more
National Cancer Institute (NCI) 110
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT01134250
What this trial is testing

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

Who this might be right for
Solid TumorBreast CancerMetastatic Melanoma+1 more
Philogen S.p.A. 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320
What this trial is testing

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more
Immuneering Corporation 209
Not applicableStudy completedNCT01927887
What this trial is testing

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

Who this might be right for
Papillary Carcinoma of Thyroid GlandMetastatic Medullary Thyroid CancerFollicular Thyroid Cancer Lymph Node Metastasis
Massachusetts General Hospital 12
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Testing effectiveness (Phase 2)UnknownNCT05094804
What this trial is testing

OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Who this might be right for
CancerTumor, SolidMalignant Neoplasm+7 more
OncoResponse, Inc. 172
Testing effectiveness (Phase 2)Looking for participantsNCT07016230
What this trial is testing

Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)

Who this might be right for
Metastatic/Locally Advanced Small-Cell Lung CancerMetastatic/Locally Advanced Poorly Differentiated NECMetastatic/Locally Advanced High-grade MTC
Gustave Roussy, Cancer Campus, Grand Paris
Testing effectiveness (Phase 2)Study completedNCT00940225
What this trial is testing

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Who this might be right for
Solid TumorsCancer
Exelixis 730
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613
What this trial is testing

Cediranib in Combination With Olaparib in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more
National Cancer Institute (NCI) 122
Not applicableUnknownNCT05377788
What this trial is testing

Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaEGFR T790M
Samsung Medical Center 900
Testing effectiveness (Phase 2)WithdrawnNCT05840770
What this trial is testing

Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8
City of Hope Medical Center
Early research (Phase 1)Looking for participantsNCT06108479
What this trial is testing

Study of DF6215 in Patients with Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultSolid Tumor Cancer
Dragonfly Therapeutics 255
Load More Results
40